영문으로 운영되고 있는 삼성바이오에피스 SNS에 포스팅된 글입니다.
[Re:Access] Newsletter Issue #12 – Biosimilar Impact on Immunology Patients...
2026/08/12
[Re:Access] Newsletter Issue #11 - Re:Access Recap: 6 Biosimilar Industry H...
2026/07/10
[Re:Access] Newsletter Issue #10 - Sustaining the Biosimilar Market: Compet...
2026/06/10
[Re:Access] Newsletter Issue #9 - Biosimilars Are Advancing. Policy Must Ke...
2026/05/19
Celebrating A Decade of Samsung Bioepis’ First Biosimilar in Europe – Behin...
2026/04/21
[Re:Access] Newsletter Issue #8 - Comparability: The 30-Year-Old Principle ...
2026/04/09